The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥1,064.37Fair value¥2,476.23Bull¥3,591.42
FairClose
52-week traded range
52W low ¥1,800.0052W high ¥2,774.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Livero Inc. closed at ¥1,945.00, 21.5% below the consensus fair value of ¥2,476.23 drawn from 9 valuation models.
Financial DNA score 65/100 — Strong. P/E of 19.3x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥3,591.42
+84.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥1,064.37
-45.3%
√(22.5 × EPS × BVPS)
EPS=100.96, BVPS=498.72 · outside Graham range (P/E 19.3, P/B 3.9) — asset-light, treat as a rough floor
P/E Fair Value
¥2,019.20
+3.8%
EPS × 20x (sector P/E)
EPS=100.96, Sector P/E=20x
Peter Lynch (PEG)
¥2,233.24
+14.8%
EPS × Growth% (PEG = 1 is fair)
EPS=100.96, g=22.1%
EV/EBITDA
¥2,867.74
+47.4%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=838.91M
Dividend Discount (DDM)
¥1,617.46
-16.8%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=29.95, r=10%, g=8%
Book Value (P/B)
¥1,957.47
+0.6%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=498.72, ROE=21.7%, g=6%, r=10%
Reverse DCF
¥1,945.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 6.6% | Historical: 22.1%
Margin of Safety
¥1,668.75
-14.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2225, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.